Dr Harithsa Srinath Asuri, MD in Ashtabula, OH - Medicare Addiction Medicine

Dr Harithsa Srinath Asuri, MD is a medicare enrolled "Internal Medicine - Addiction Medicine" physician in Ashtabula, Ohio. He graduated from medical school in 2016 and has 8 years of diverse experience with area of expertise as Addiction Medicine. He is a member of the group practice Brightview Llc and his current practice location is 2210 S Ridge Rd E, Ashtabula, Ohio. You can reach out to his office (for appointments etc.) via phone at (513) 834-7063.

Dr Harithsa Srinath Asuri is licensed to practice in Ohio (license number 35.139465) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1417311200.

Contact Information

	Dr Harithsa Srinath Asuri, MD
	2210 S Ridge Rd E, Ashtabula, OH 44004-4459
	(513) 834-7063
	(513) 873-1567

Physician's Profile

Full Name	Dr Harithsa Srinath Asuri
Gender	Male
Speciality	Addiction Medicine
Experience	8 Years
Location	2210 S Ridge Rd E, Ashtabula, Ohio
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Harithsa Srinath Asuri graduated from medical school in 2016

NPI Data:

NPI Number: 1417311200
Provider Enumeration Date: 04/08/2016
Last Update Date: 07/16/2020

Medicare PECOS Information:

PECOS PAC ID: 9436445541
Enrollment ID: I20200921002648

Medical Identifiers

Medical identifiers for Dr Harithsa Srinath Asuri such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1417311200	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RA0401X	Internal Medicine - Addiction Medicine	35.139465 (Ohio)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Brightview Llc	9032426044	140

News Archive

UHN, Boehringer Ingelheim partner to improve care, education and support for hepatitis C patients

In a move to address a significant unmet need in hepatitis C in Canada, the University Health Network, together with Boehringer Ingelheim (Canada) Ltd., announced today a multi-year partnership that aims to improve care, education and support for patients with hepatitis C. The program, known as Link-C, aims to improve access to hepatitis C care and treatment in remote areas of Ontario and other parts of Canada.

AbbVie begins six global Phase 3 clinical studies to evaluate efficacy of investigational HCV regimen

AbbVie, a global biopharmaceutical company, today announced the initiation of six global Phase 3 clinical studies evaluating the safety and efficacy of its all-oral, once-daily, ribavirin-free investigational hepatitis C virus (HCV) regimen, ABT-493, an NS3/4A protease inhibitor, and ABT-530, an NS5A inhibitor, in patients with genotypes 1-6 (GT1-6) chronic HCV infection.

Cisplatin plus radiotherapy and HDRB proves beneficial in stage IIIB cervical cancer

Adding the chemotherapy drug cisplatin to a treatment plan of radiation therapy (RT) and high-dose-rate brachytherapy (HDRB) for stage IIIB cervical cancer is beneficial, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

Media coverage of potential link between hormonal contraception, HIV risk needed more 'critical thinking'

In a Nature News opinion piece, James Shelton, science adviser for USAID's Bureau for Global Health, discusses media coverage of recent findings from the journal Lancet Infectious Diseases showing that women's use of hormonal contraception (HC) may increase the risk of HIV acquisition or transmission.

Utah voters approved Medicaid expansion, but state lawmakers are balking

Utah residents may have thought they were done fighting about Medicaid expansion last November. But when Utah lawmakers opened a new legislative session in late January, they began pushing through a bill to roll back the scope and impact of an expansion that voters approved in a ballot measure.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Harithsa Srinath Asuri allows following entities to bill medicare on his behalf.

Entity Name	Brightview Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1659769446 PECOS PAC ID: 9032426044 Enrollment ID: O20150923000820

News Archive

UHN, Boehringer Ingelheim partner to improve care, education and support for hepatitis C patients

AbbVie begins six global Phase 3 clinical studies to evaluate efficacy of investigational HCV regimen

Cisplatin plus radiotherapy and HDRB proves beneficial in stage IIIB cervical cancer

Media coverage of potential link between hormonal contraception, HIV risk needed more 'critical thinking'

Utah voters approved Medicaid expansion, but state lawmakers are balking

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Harithsa Srinath Asuri is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Harithsa Srinath Asuri, MD 615 Elsinore Pl Ste 200, Cincinnati, OH 45202-1459 Ph: (513) 834-7063	Dr Harithsa Srinath Asuri, MD 2210 S Ridge Rd E, Ashtabula, OH 44004-4459 Ph: (513) 834-7063

News Archive

UHN, Boehringer Ingelheim partner to improve care, education and support for hepatitis C patients

AbbVie begins six global Phase 3 clinical studies to evaluate efficacy of investigational HCV regimen

Cisplatin plus radiotherapy and HDRB proves beneficial in stage IIIB cervical cancer

Media coverage of potential link between hormonal contraception, HIV risk needed more 'critical thinking'

Utah voters approved Medicaid expansion, but state lawmakers are balking

Internal Medicine Doctors in Ashtabula, OH

Arthur W Molinoff, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2121 Lake Avenue, Ashtabula, OH 44004 Phone: 440-998-4775 Fax: 440-998-5922
Dr. Mohammad Ali Varghai, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2420 Lake Ave, Ashtabula, OH 44004 Phone: 440-994-7600 Fax: 440-994-7603
Dr. Kelvin Arlson Cenac, MBBS Internal Medicine Medicare: Medicare Enrolled Practice Location: 2420 Lake Ave, Ashtabula, OH 44004 Phone: 409-972-2624
Edward A Wiese, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2422 Lake Ave, Ashtabula, OH 44004 Phone: 440-992-4422
Mrs. Courtney Dean Borruso, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2131 Lake Ave Suite 4, Ashtabula, OH 44004 Phone: 440-964-3733 Fax: 440-964-7069
Dr. Orlando Antonio Dsilva, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 Lake Ave, Ashtabula, OH 44004 Phone: 440-964-7121 Fax: 440-964-2251

Dr Harithsa Srinath Asuri, MD - Medicare Addiction Medicine in Ashtabula, OH

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

UHN, Boehringer Ingelheim partner to improve care, education and support for hepatitis C patients

AbbVie begins six global Phase 3 clinical studies to evaluate efficacy of investigational HCV regimen

Cisplatin plus radiotherapy and HDRB proves beneficial in stage IIIB cervical cancer

Media coverage of potential link between hormonal contraception, HIV risk needed more 'critical thinking'

Utah voters approved Medicaid expansion, but state lawmakers are balking

Medicare Reassignments

UHN, Boehringer Ingelheim partner to improve care, education and support for hepatitis C patients

AbbVie begins six global Phase 3 clinical studies to evaluate efficacy of investigational HCV regimen

Cisplatin plus radiotherapy and HDRB proves beneficial in stage IIIB cervical cancer

Media coverage of potential link between hormonal contraception, HIV risk needed more 'critical thinking'

Utah voters approved Medicaid expansion, but state lawmakers are balking

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

UHN, Boehringer Ingelheim partner to improve care, education and support for hepatitis C patients

AbbVie begins six global Phase 3 clinical studies to evaluate efficacy of investigational HCV regimen

Cisplatin plus radiotherapy and HDRB proves beneficial in stage IIIB cervical cancer

Media coverage of potential link between hormonal contraception, HIV risk needed more 'critical thinking'

Utah voters approved Medicaid expansion, but state lawmakers are balking

Internal Medicine Doctors in Ashtabula, OH